Summaries of the Section H (HML) update

Each month we issue a summary of the HML update. The table on this page gives a preview of the upcoming changes.

The full Update will be available as a PDF on our website(external link) 

The changes will be published in the online HML around the 23rd of this month and are effective from next month.

For any questions about these listing changes or the Pharmaceutical Schedule in general, email us at enquiry@pharmac.govt.nz.

19 October 2021 - preview of changes for November 2021

Pharmaceutical

Change

Amisulpride (Sulprix) tab 100 mg

new listing (p’code 2609401)

Aqueous cream (Pharmacy Health SLS-free) crm 100 g

to be delisted 1 April 2022

Aqueous cream crm 500 g

Brand change

  • GEM Aqueous Cream – new listing and addition of PSS (p’code 2615592)
  • Boucher – to be delisted 1 April 2022

Beclomethasone dipropionate (Qvar) aerosol inhaler 50 mcg per dose and 100 mcg per dose, 200 dose

price increase

Bimatoprost (Bimatoprost Multichem) eye drops 0.03%, 3 ml

price increase and addition of PSS

Bortezomib inj 2.5 mg vial

new presentation listing

Calcium gluconate with calcium carbonate tab eff 2.94 g with calcium carbonate 0.3 g (500 mg elemental)

new listing

Cetomacrogol (helathE) crm BP, 100 g

to be delisted 1 April 2022

Ciclopirox olamine (Apo-Ciclopirox) nail soln 8%, 7 ml

to be delisted 1 May 2022

Cinacalcet tab 30 mg and 60 mg

Brand change

Cinacalcet Devatis – new listing and addition of PSS

  • Tab 30 mg (p’code 2615517)
  • Tab 60 mg (p’code 2615525)

Sensipar tab 30 mg – to be delisted 1 April 2022

Darunavir (Darunavir Mylan) tab 400 mg

new listing of bottle pack (p’code 2591286)

Entacapone tab 200 mg

Brand change

  • Comtan – new listing and addition of PSS (p’code 2536471)
  • Entapone – to be delisted 1 April 2022

Fentanyl (Boucher and Muir) inj 50 mcg per ml, 2 ml ampoule

price increase and addition of PSS

Fentanyl (Boucher and Muir) inj 50 mcg per ml, 10 ml ampoule

addition of PSS

Folic acid tab 0.8 mg

Brand change

  • Folic Acid multichem – new listing (p’code 2610566)
  • Apo-Folic acid – to be delisted 1 May 2022

Flucytosine tab 500 mg

new presentation listing

Gentamicin sulphate (DBL Gentamicin) inj 10 mg per ml, 1 ml ampoule

price increase

Gentamicin sulphate inj 10 mg per ml, 2 ml ampoule

new presentation listing

Ibuprofen (Ethics) oral liq 20 mg per ml, 200 ml

price increase and addition of PSS

Infliximab (Remicade) inj 100 mg

amended restriction criteria

Melatonin tab modified-release 2 mg

Brand change

  • Vigisom – new listing and addition of PSS (p’code 2612593)
  • Circadin – to be delisted 1 April 2022

Methyldopa (Methyldopa Mylan) tab 250 mg

new listing (p’code 2603934)

Nepafenac (Ilevro) eye drops 0.3%

delist delayed to 1 February 2022

Oxybutynin (Apo-Oxybutynin) tab 5 mg

to be delisted 1 May 2022

Prazosin (Apo-Prazosin) tab 1 mg, 2 mg and 5 mg

removal of restriction

Prazosin (Apo-Prazosin S29) tab 1 mg, 2 mg and 5 mg

new listing

  • Tab 1 mg (p’code 2625725)
  • Tab 2 mg (p’code 2625733)
  • Tab 5 mg (p’code 2625741)

Pyridoxine hydrochloride tab 50 mg

Brand change

  • Pyridoxine multichem – new listing (p’code 2610582)
  • Apo-Pyridoxine – to be delisted 1 May 2022

Rituximab (Riximyo) inj 10 mg per ml, 10 ml vial and inj 10 mg per ml, 50 ml vial

amended restriction criteria

Rivastigmine (Generic Partners) patch 9.5 mg per 24 hour

price decrease

Secukinumab (Cosentyx) inj 150 mg per ml, 1 ml prefilled syringe

amended restriction criteria

Sodium chloride (Baxter-Viaflo) inj 0.9%, 50 ml bag and 100 ml bag

new listing

  • Inj 0.9%, 50 ml bag, 75 bags (p’code 2625857)
  • Inj 0.9%, 100 ml bag, 60 bags (p’code 2625865)

Testosterone undecanoate (Andriol Testocaps) cap 40 mg

addition of restriction

Zinc and castor oil (Boucher) oint, 500 g

price increase